Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Morphine-Like Synthetic Pain Killer Lacks Side Effects

By LabMedica International staff writers
Posted on 06 Jun 2011
A team of pharmaceutical chemists has successfully synthesized conolidine, a rare natural product that is a potent analgesic as effective as morphine in alleviating inflammatory and acute pain, with few, if any, side effects.

Management of chronic pain is usually based on opioid analgesics despite the fact that they suffer from substantial liabilities that include addiction and tolerance, as well as depression of breathing, nausea, and chronic constipation.

In the current study investigators at the Scripps Research Institute (Jupiter, FL, USA) sought to develop a method for the synthesis of conolidine, a rare C5-nor stemmadenine natural product recently isolated from the stem bark of Tabernaemontana divaricata (a tropical flowering plant used in traditional Chinese, Ayurvedic, and Thai medicine). More...
Details of their research were published in the May 23, 2011, online edition of the journal Nature Chemistry.

"This was a classic problem in chemical synthesis," said Dr. Glenn Micalizio, associate professor in of chemistry at the Scripps Research Institute, "which we were able to solve effectively and efficiently--an achievement that made subsequent assessment of the potential therapeutic properties of this rare natural product possible."

The synthetic conolidine was tested in a mouse model of tonic and persistent pain. Results showed that the new synthetic compound suppressed acute pain and inflammatory-derived pain, two key measures of efficacy. The new compound passed easily through the blood-brain barrier, and was present in the brain and blood at relatively high concentrations up to four hours after injection.

"Pharmacological studies confirmed that while it is not an opiate, it is nearly as potent as morphine," said Dr. Micalizio.

Related Links:

Scripps Research Institute





Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.